Walgreens agreed to pay the United States $300M, plus interest at a rate of 4.00% per annum accruing from October 20, 2024, of which $150M shall constitute restitution, to resolve False Claims Act allegations. Th settlement is neither an admission of liability by Walgreens nor a concession by the United States that its claims are not well founded, according to a court filing.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Arrowhead CFO Ken Myszkowski to retire, Daniel Apel to succeed
- Hold Rating on Walgreens Boots Alliance Amid Mixed Performance and Acquisition Uncertainty
- Walgreens Boots Alliance Reports Q2 Fiscal 2025 Results
- Unusually active option classes on open April 8th
- Morning Movers: Stock futures rebound following days of dips
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue